IBL Indrayani Biotech has announced the publication of its audited financial results for the quarter and year ended March 31, 2026. The company's Board of Directors approved these results at a meeting.

This update provides shareholders with a transparent overview of IBL's recent financial performance.

Investors can access the detailed standalone and consolidated financial results, along with the audit reports, on the company's official website to stay informed on its latest financial health.